To most, it’s Silicon Valley: the region that produced silicon chip innovators and manufacturers, globally influential high-tech corporations and thousands upon thousands of startup companies.
One local surgeon, however, likes to refer to the area as “Vascular Valley,” acknowledging the prolific development of minimally invasive medical device technology. And who would know better than a man who created a new and innovative way to treat patients at risk for stroke?
For Dr. David Chang, a vascular surgeon from Cupertino whose office is in Los Gatos, innovation is a way of life. With more than 10 patents to his name over the course of 16 years of professional practice experience, Chang’s biggest achievement to date is the development of a minimally invasive technique to treat blockages in the carotid artery at risk of causing a stroke. The procedure, called “transcarotid artery revascularization,” or TCAR, has the potential to be used as an alternative to the traditional open surgical technique of carotid endarterectomy (CEA). CEA is a more invasive surgical technique requiring a larger incision and can be at a higher risk for nerve injury and typical complications from open surgery like infection and bleeding.
Read More: http://www.mercurynews.com/2016/11/03/los-gatos-surgeon-comes-up-with-a-new-approach-to-treat-stroke-patients/
Via: The Mercury News
Comments are closed.